The dose can be increased at 4-week intervals to 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg per week as needed to sustain weight loss
Continuous improvement of the pharmacokinetic profile of GLP-1R agonists, starting from native hormone with a half-life of ~23 min to the development of twice daily, daily and even once-weekly drugs highlight the pharmaceutical evolution of GLP-1-based medicines
Unfer, V., Dinicola, S., Lagan, A
People Committed to a Healthy Lifestyle: While GLP-1 shots can significantly aid weight loss, they are most effective when combined with a balanced diet and regular exercise
Patients With Class II Obesity and Serious Comorbidities These include: Type 2 diabetes mellitus Obstructive sleep apnea Hypertension Dyslipidemia Non-alcoholic fatty liver disease Michigan Medicaids updated clinical guidelines mirror the states existing requirements for bariatric surgery coverage, which similarly use BMI thresholds and comorbidities as qualifying criteria (MDHHS, 2023)